1Joaquim Ruiz.Mechanisms of resistance to quinolones:target alterations,decreased accumulation and DNA gyrase protection[J].Journal of Antimicrobial Chemotherapy,2003,51:1109-1117. 被引量：1
2Thomas J.Dougherty,Danielle Beaulieu and John F.Barrett.New quinolones and the impact on resistance[J].DDT Vol,2001(6):529-536. 被引量：1
3Janet E.Stout,Kelly Sens,et al.Comparative activity of quinolones,macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing[J].International Journal of Antimicrobial Agents,2005,25:302-307. 被引量：1
4Siempos I.I.,Dimopoulos G,Korbila I.P,et al.Macrolides,quinolones and amoxicillin/clavulanate for chronic bronchitis:a meta-analysis[J].Eur Respir J,2007,29:1127-1137. 被引量：1
5Shin-ichi Yokota,Yasuo Ohkoshi,Nobuhiro Fujii.Susceptibility and bactericidal activity of 8 oral quinolones against conventional-fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates[J].Diagnostic Microbiology and Infectious Disease,2009,65:76-80. 被引量：1
6María Pérez-Vázquezl,Federico Románl M,Carmen Varela2,Rafael Cantón2 and José Campos1.Activities of 13 quinolones by three susceptibility testing methods against a collection of Haemophilus influenzae isolates with different levels of susceptibility to ciprofloxacin:evidence for cross-resistance[J].Journal of Antimicrobial Chemotherapy,2003,51:147-151. 被引量：1
7George G.Zhanel,Daryl J,et al.Role of efflux mechanisms on fluoroquinolone resistance in Streptococcus pneumoniae and Pseudomonas aeruginosa[J].International Journal of Antimicrobial Agents,2004,24:529-535. 被引量：1
8Auberta G,Carricajoa A,Vautrina A.-C,et al.Impact of restricting fluoroquinolone prescription on bacterial resistance in an intensive care unit[J].Journal of Hospital Infection,2005,59:83-89. 被引量：1
7KatzE, Larsen LS, FogartlyCM, et al. Safety and efficacy of sequential iv Moxifloxacin in versus conventional combination therapies for the threatment of CAP in patients requiring intital iv therapy. Emerg Med, 2004, 27 (4) : 395 - 405. 被引量：1
8andell Lgemifloxacin Surrival of the fittest.Antimicrob Chemother,2000,46:33-37. 被引量：1
8Tillotson GS,Blondeau JM. Structure-activity-function al- uation of the fluoroquinolones. In Moxifloxacin in Practice [J]. Maxim Medical, 1999,20(1) :91-101. 被引量：1
